Evidence map›Paper›PMID 40760040›Full record

ArticleNature immunology2025

Author Correction: LARP4-mediated hypertranslation drives T cell dysfunction in tumors.

Yi Liu, Haochen Ni, Jie Li, Jing Yang, Ivann Sekielyk, Bryan E Snow, Zihao Zhang, Feifan Zhang, Michael St Paul, Jinyi Han and 9 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Yi Liu *Institute for Immunology, Tsinghua University, Beijing, China.
Haochen Ni *China National Center for Bioinformation, Beijing, China.
Jie Li *China National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0002-4732-5967
Jing YangChina National Center for Bioinformation, Beijing, China.ORCID http://orcid.org/0000-0001-5199-7435
Ivann SekielykPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Bryan E SnowPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Zihao ZhangInstitute for Immunology, Tsinghua University, Beijing, China.
Feifan ZhangChina National Center for Bioinformation, Beijing, China.
Michael St PaulPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0002-5213-6415
Jinyi HanInstitute for Immunology, Tsinghua University, Beijing, China.
Meghan KatesPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Shaofeng LiuPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Yawei ZhangChina National Center for Bioinformation, Beijing, China.
Zurui HuangChina National Center for Bioinformation, Beijing, China.
Yin XuChina National Center for Bioinformation, Beijing, China.
Samuel D SaibilPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Tak W MakPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-6766-861X
Dali HanChina National Center for Bioinformation, Beijing, China. handl@big.ac.cn.ORCID http://orcid.org/0000-0001-7119-1578
Meng Michelle XuInstitute for Immunology, Tsinghua University, Beijing, China. michellexu@mail.tsinghua.edu.cn.ORCID http://orcid.org/0009-0007-1639-5640

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40760040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.